Nonadherent, clinical inertia, or therapeutic inertia?

Journal of Managed Care Pharmacy

Volumn 15, Issue 8, 2009, Pages 690-695

  Allen, J Daniel ^a   Curtiss, Frederic R ^b   Fairman, Kathleen A ^b  

^a RegenceRx   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

BLOOD PRESSURE REGULATION; BODY MASS; BYPASS SURGERY; CORONARY ARTERY DISEASE; EDITORIAL; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; LIFESTYLE; LIPID BLOOD LEVEL; MEDICAID; MEDICAL LITERATURE; MEDLINE; OBESITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; QUALITY CONTROL; RISK FACTOR; SMOKING; THERAPEUTIC INERTIA; THERAPY EFFECT; TREATMENT FAILURE; CLINICAL PRACTICE; NOMENCLATURE; PSYCHOLOGICAL ASPECT; STANDARD; TREATMENT REFUSAL;

HUMANS; MEDICATION ADHERENCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; TERMINOLOGY AS TOPIC; TREATMENT REFUSAL;

EID: 70449672770     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2009.15.8.690     Document Type: Editorial

References (40)

1. Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10(7):481-86. Available at: http://www.ajmc.com/media/pdf/A107julPrt2-Andrade481-86.pdf. Accessed September 27, 2009. (Pubitemid 38970231)
2. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-34. Available at: http://www.annals.org/cgi/reprint/135/9/825. pdf. Accessed September 27, 2009.
3. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47(3):345-51. Available at: http://hyper.ahajournals.org/cgi/reprint/47/3/345. Accessed September 27, 2009. (Pubitemid 43740273)
4. O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. April 2005. Agency for Healthcare Research and Quality. Available at: http://www.ahrq.gov/downloads/pub/advances/ vol2/OConnor.pdf. Accessed September 27, 2009.
5. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326(7404):1419. Available at: http://www.bmj.com/cgi/reprint/326/ 7404/1419. Accessed September 27, 2009.
6. Zolnierek KB, DiMatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826-834
7. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462-467 (Pubitemid 34787477)
8. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-461 (Pubitemid 34787476)
9. Brookhart MA, Patrick AR, Schneeweiss S, et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007;167(8):847-52. Available at: http://archinte.ama-assn.Org/cgi/reprint/167/8/847. Accessed September 27, 2009. (Pubitemid 46658345)
10. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147-1152
11. Doshi JA, Zhu J, Lee BY, Kimmel S, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation. 2009;119(3):390-97. Available at: http://circ.ahajournals.org/cgi/ reprint/119/3/390. Accessed September 27, 2009.
12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497
13. Kurlander JE, Kerr EA, Krein S, Heisler M, Piette JD. Cost-related non-adherence to medications among patients with diabetes and chronic pain: factors beyond finances. Diabetes Care. 2009 Sep 3 (Epub ahead of print).
14. Sud A, Kline-Rogers EM, Eagle KA, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39(11):1792-1797 (Pubitemid 41527689)
15. Melloni C, Alexander KP, Ou FS, et al. Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol 2009;104(2):175-181
16. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929-940
17. EUROASPIRE Study Group. EUROASPIRE: a European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18(10):1569-82. Available at: http://eurheartj.oxfordjournals. org/cgi/reprint/18/10/1569. Accessed September 27, 2009.
18. King DE, Mainous AG 3rd, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in U.S. adults, 1988-2006. Am J Med. 2009;122(6):528-534
19. Centers for Disease Control and Prevention (CDC). State-specific prevalence of obesity among adults - United States, 2005. Morb Mortal Wkly Rep. 2006;55(36):985-88. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5536al.htm. Accessed September 27, 2009.
20. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-98. Available at: http://content.nejm.org/cgi/reprint/356/23/2388.pdf. Accessed September 27, 2009.
21. Capewell S, Ford E, Hayes D, O'Flaherty M, Critchley J, Unal B. IMPACT, a validated, comprehensive coronary heart disease model. Supplementary appendix for the U.S. model. November 2006. Available at: http://content.nejm.Org/cgi/ data/356/23/2388/DCl/l. Accessed September 27, 2009.
22. Meier B. Diabetes case shows pitfalls of treatment rules. NY Times. August 18, 2009. Available at: http://www.nytimes.com/2009/08/18/health/policy/ 18diabetes.html?-r=l&th&emc=th. Accessed September 27, 2009.
23. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59. Available at: http://content.nejm.org/cgi/reprint/358/24/ 2545.pdf. Accessed September 27, 2009.
24. Hughes S. NCQA to omit lower blood sugar target from performance measures. Heartwire. July 18, 2009. Available at: http://www.theheart.org/ article/883157.do. Accessed September 27, 2009.
25. Curtiss FR, Fairman KA. Looking for the outcomes we love in all the wrong places: the questionable value of biomarkers and investments in chronic care disease management interventions. J Manag Care Pharm. 2008;14(6):563-570 Available at: http://www.amcp.org/data/jmcp/JMCPMaga-563-570.pdf.
26. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884-893
27. Campbell NC, Murchie P. Treating hypertension with guidelines in general practice. BMJ. 2004;329(7465):523-24. Available at: http://www.bmj.com/cgi/ reprint/329/7465/523. Accessed September 27, 2009. (Pubitemid 39215197)
28. Curtiss FR. Asthma disease management - evidence-based medicine must be dynamic. J Manag Care Pharm. 2006;12(1):80-82. Available at: http://amcp.org/data/jmcp/editorial-subjects-80-82.pdf.
29. Centers for Medicare & Medicaid Services. Office of Clinical Standards and Quality. Fact Sheet, CMS updated the national hospital quality measure acute myocardial infarction set for discharges as of April 1, 2009. December 31, 2008. Available at: http://www.cms.hhs.gov/HospitalQualityInits/ downloads/HospitalAMI-6FactSheet.pdf. Accessed September 27, 2009.
30. DerGurahian J. All good quality intentions...don't always do good, CMS measure suggests. Mod Healthc. 2009;39(32):8-9.
31. Chen ZM, Pan HC, Chen YP, et al.; COMMIT (CLOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1622-1632
32. Amman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008;117(2):296-329. Epub 2007 Dec 10. Available at: http://circ.ahajournals. org/cgi/reprint/117/2/296. Accessed September 27, 2009.
33. Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. JAMA. 2009;302(11):1186-1194
34. Keenan K, Hayen A, Neal BC, Irwig L. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ. 2009;338:b1492. Available at: http://www.bmj.com/cgi/reprint/338/apr30-1/b1492. Accessed September 27, 2009.
35. Gruchalla RS, Sampson HA, Matsui E, et al. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol 2009;124(2):213-21. Abstract available at: http://www.jacionline.org/article/S0091-6749(09)00860-4/ abstract. Accessed September 27, 2009.
36. U.S. National Library of Medicine. Fact Sheet MEDLINE. April 22, 2008. Available at: http://www.nlm.nih.gov/pubs/factsheets/medline.html. Accessed September 27, 2009.
37. U.S. National Library of Medicine. Detailed indexing statistics: 1965-2008. Available at: http://www.nlm.nih.gov/bsd/index-stats-comp.html. Accessed September 28, 2009.
38. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care. 2005;28(3):600-06. Available at: http://care.diabetesjournals.org/content/28/3/600.full.pdf. Accessed September 27, 2009. (Pubitemid 40326231)
39. Fairman KA, Curtiss FR. Still looking for health outcomes in all the wrong places? Misinterpreted observational evidence, medication adherence promotion, and value-based insurance design. J Manag Care Pharm. 2009;15(6):501-507 Available at: http://www.amcp.org/data/jmcp/501-507.pdf.
40. Anonymous. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence in chronic disease. New England Healthcare Institute. August 12, 2009. Available at: http://www.nehi.net/ publications/44/thinking-outside-the-pillbox-a-systemwide-approach-to-improving- patient-medication-adherence-for-chronic-disease. Accessed September 27, 2009.